Detalhe da pesquisa
1.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
N Engl J Med
; 389(1): 33-44, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407001
2.
Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL.
J Infect Dis
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437622
3.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet
; 397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676628
4.
Endoscopy Is Not Associated with Infectious Adverse Events After Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
Dig Dis Sci
; 67(6): 2310-2319, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050445
5.
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Haematologica
; 106(6): 1705-1713, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414850
6.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973276
7.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324220
8.
Managing adverse effects of immunotherapy.
Clin Adv Hematol Oncol
; 16(5): 364-374, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29851932
9.
Temporal artery biopsy revealing marginal zone lymphoma in a patient with eosinophilic granulomatosis with polyangiitis.
Rheumatology (Oxford)
; 61(3): 1295-1296, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999129
10.
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma.
Transplant Cell Ther
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494076
11.
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.
Blood Adv
; 8(3): 653-666, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113468
12.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Nat Med
; 30(4): 984-989, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266761
13.
The CNS Relapse in T-Cell Lymphoma Index Predicts CNS Relapse in Patients with T- and NK-Cell Lymphomas.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739715
14.
PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation.
Cold Spring Harb Mol Case Stud
; 9(4)2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199780
15.
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.
Clin Transl Radiat Oncol
; 39: 100587, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718252
16.
Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T Cells.
Transplant Cell Ther
; 29(8): 495-503, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211154
17.
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
Blood Adv
; 7(11): 2287-2296, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516079
18.
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
J Clin Oncol
; 41(24): 3988-3997, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192437
19.
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
Blood Adv
; 7(24): 7393-7401, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874912
20.
Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas.
Oncotarget
; 13: 1237-1244, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441737